HIV-gp120 can block CD4-class II MHC-mediated adhesion - PubMed (original) (raw)

. 1990 Jan 15;144(2):526-31.

Affiliations

PMID: 1967269

HIV-gp120 can block CD4-class II MHC-mediated adhesion

Y Rosenstein et al. J Immunol. 1990.

Abstract

A possible component of the immune dysfunction associated with infection by HIV is the inhibition of CD4 function resulting from the avid binding of soluble HIV envelope glycoprotein (gp120) to cell surface CD4. We assessed CD4 function by measuring the ability of CD4+ T cells to form conjugates with cell size lipid vesicles, artificial target cells (ATC), bearing the natural ligand for CD4, MHC class II proteins. Conjugate formation was a transient process with the greatest number of specific cell to ATC conjugates found after approximately 30 min of incubation at 37 degrees C. Addition of gp120 specifically blocked conjugates between CD4+ cells and class II ATC in a concentration-dependent manner. These data indicate that T lymphocyte adhesion mediated by CD4 is a dynamic event and that binding of gp120 to CD4 is able to disrupt the normal progression of the interaction between CD4+ T lymphocytes and class II+ APC.

PubMed Disclaimer

Cited by

Increased, Durable B-Cell and ADCC Responses Associated with T-Helper Cell Responses to HIV-1 Envelope in Macaques Vaccinated with gp140 Occluded at the CD4 Receptor Binding Site.
Bogers WMJM, Barnett SW, Oostermeijer H, Nieuwenhuis IG, Beenhakker N, Mortier D, Mooij P, Koopman G, Remarque E, Martin G, Lai RP, Dey AK, Sun Y, Burke B, Ferrari G, Montefiori D, Martin L, Davis D, Srivastava I, Heeney JL. Bogers WMJM, et al. J Virol. 2017 Sep 12;91(19):e00811-17. doi: 10.1128/JVI.00811-17. Print 2017 Oct 1. J Virol. 2017. PMID: 28701402 Free PMC article.
Patterns of immune, neuroendocrine, and cardiovascular stress responses in asymptomatic HIV seropositive and seronegative men.
Starr KR, Antoni MH, Hurwitz BE, Rodriquez MS, Ironson G, Fletcher MA, Kumar M, Patarca R, Lutgendorf SK, Quillian RE, Klimas NG, Schneiderman N. Starr KR, et al. Int J Behav Med. 1996;3(2):135-62. doi: 10.1207/s15327558ijbm0302_4. Int J Behav Med. 1996. PMID: 16250760 No abstract available.
The Role of the Envelope Glycoprotein in the Depletion of T Helper Cells in Human Immunodeficiency Virus Infection.
Jassoy C, Heinkelein M, Sopper S. Jassoy C, et al. Pathol Oncol Res. 1997;3(1):62-67. doi: 10.1007/BF02893356. Pathol Oncol Res. 1997. PMID: 11173628
Envelope glycoproteins of human immunodeficiency virus type 1: profound influences on immune functions.
Chirmule N, Pahwa S. Chirmule N, et al. Microbiol Rev. 1996 Jun;60(2):386-406. doi: 10.1128/mr.60.2.386-406.1996. Microbiol Rev. 1996. PMID: 8801439 Free PMC article. Review.
Identification of CD4 and major histocompatibility complex functional peptide sites and their homology with oligopeptides from human immunodeficiency virus type 1 glycoprotein gp120: role in AIDS pathogenesis.
Zagury JF, Bernard J, Achour A, Astgen A, Lachgar A, Fall L, Carelli C, Issing W, Mbika JP, Picard O, et al. Zagury JF, et al. Proc Natl Acad Sci U S A. 1993 Aug 15;90(16):7573-7. doi: 10.1073/pnas.90.16.7573. Proc Natl Acad Sci U S A. 1993. PMID: 8356059 Free PMC article.

HIV-gp120 can block CD4-class II MHC-mediated adhesion - PubMed (original) (raw)